Notice: This company has been marked as potentially delisted and may not be actively trading. Innovate Biopharmaceuticals (INNT) News Today Add Compare Share Share Headlines Stock AnalysisCompetitorsHeadlinesTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period InnovationRx: Positive Clinical Trial Results For Generative AI-Designed DrugNovember 14, 2024 | forbes.comGilead's Stock Surge: What's Fueling the Momentum?November 9, 2024 | msn.comCRISPR Therapeutics to Present at the Guggenheim Inaugural Healthcare Innovation ConferenceNovember 8, 2024 | markets.businessinsider.comPfizer Inc. Reports Strong Q3 2024 Results, Raises GuidanceOctober 30, 2024 | msn.comInozyme Pharma Inc.: Inozyme Pharma Announces Positive Interim Data from Phase 1 SEAPORT 1 Trial of INZ-701October 27, 2024 | finanznachrichten.de6 Launch Challenges Biopharmaceutical Companies Face (And Possible Solutions)October 23, 2024 | forbes.comStrategic Partnership Between Matica Bio and Mongoose Bio to Accelerate TCR-T Cell Therapy DevelopmentOctober 16, 2024 | businesswire.com3 Biotech Stocks Set to Revolutionize MedicineOctober 15, 2024 | stocknews.comImpact BioMedical Inc. (NYSE American: IBO) Announces IPO Participation with Strong Support from Partners and AffiliatesOctober 7, 2024 | markets.businessinsider.comCherry Bekaert CEO Michelle Thompson Joins Board of Managers for The Innovate FundOctober 4, 2024 | finance.yahoo.comBuy Rating Issued for Context Therapeutics on CT-202’s Innovative TCE Approach and Market PotentialSeptember 24, 2024 | markets.businessinsider.comImpact BioMedical Inc. Introduces Leadership Team to Drive Innovation and GrowthSeptember 23, 2024 | tmcnet.comFMR LLC Acquires New Stake in Bicara Therapeutics IncSeptember 20, 2024 | finance.yahoo.comOrbiMed Advisors LLC Acquires New Stake in MBX Biosciences IncSeptember 18, 2024 | finance.yahoo.comONL Therapeutics Closes $65 Million in Oversubscribed Series D FinancingSeptember 13, 2024 | markets.businessinsider.comRedefining Patent Valuation In The Era Of Rapid Technological InnovationSeptember 4, 2024 | forbes.comGilead Sciences: Innovative Approaches to Healthcare Can Remove BarriersSeptember 4, 2024 | finance.yahoo.comCircle Pharma Closes $90 Million Series D Financing to Advance Innovative Oral Macrocycle TherapiesSeptember 3, 2024 | venturebeat.comOp-Ed: AI-powered innovation and executives driving new era of biotechAugust 29, 2024 | msn.comCARISMA Therapeutics Inc (W2J.SG)August 24, 2024 | uk.finance.yahoo.comCARISMA THERAPEUTICS INC. (W2J.DU)August 24, 2024 | uk.finance.yahoo.comDirector Richard Scheller Sells 44,250 Shares of Alector Inc (ALEC)August 24, 2024 | nz.finance.yahoo.comInsider Sale at Catalyst Pharmaceuticals Inc (CPRX): Chief Operating & Scientific Officer ...August 23, 2024 | finance.yahoo.comTinyGemsBreaks – Aditxt Inc. (NASDAQ: ADTX), Appili Therapeutics (TSX: APLI) (OTC: APLIF) Enter Third Amending AgreementAugust 22, 2024 | msn.comBuy Rating Affirmed on Janux Therapeutics Inc. Amidst Promising Prostate Cancer Program Developments and Unique Bispecific PlatformAugust 14, 2024 | markets.businessinsider.comEsperion Therapeutics, Inc. (NASDAQ:ESPR) Q2 2024 Earnings Call TranscriptAugust 14, 2024 | insidermonkey.comEyenovia’s Strategic Collaborations and Innovative Optejet System Underpin Buy RatingAugust 14, 2024 | markets.businessinsider.comPulmatrix Inc.: Pulmatrix Announces Second Quarter 2024 Financial Results and Provides Corporate UpdateAugust 14, 2024 | finanznachrichten.deAzitra, Inc. Announces Q2 2024 Financial Results and Provides Business UpdatesAugust 12, 2024 | finance.yahoo.comEdesa Biotech, Inc.: Edesa Biotech Reports Fiscal 3rd Quarter 2024 ResultsAugust 11, 2024 | finanznachrichten.deWerewolf Therapeutics, Inc.: Werewolf Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business UpdateAugust 8, 2024 | finanznachrichten.deMacroGenics, Inc.: MacroGenics Provides Update on Corporate Progress, Second Quarter 2024 Financial ResultsAugust 8, 2024 | finanznachrichten.deAnalysts Expect ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) To Breakeven SoonAugust 3, 2024 | finance.yahoo.comMacroGenics, Inc.: MacroGenics Announces Achievement of $100 Million in Milestones Related to Retifanlimab Collaboration with IncyteJuly 31, 2024 | finanznachrichten.deinPhronesis Announces Name Change to inThought LabsJuly 30, 2024 | tmcnet.comRosen Law Firm Urges MacroGenics, Inc. (NASDAQ: MGNX) Stockholders with Large Losses to Contact the Firm for Information About Their RightsJuly 29, 2024 | tmcnet.comImmix Biopharma, Inc.: California Institute for Regenerative Medicine Awards Funding for CAR-T NXC-201 U.S. AL Amyloidosis Clinical Trial (NEXICART-2)July 26, 2024 | finanznachrichten.deGilead Presents Research Data Across Its Broad and Innovative HIV Treatment Portfolio and PipelineJuly 26, 2024 | uk.finance.yahoo.comIPIX Innovation Pharmaceuticals Inc.July 25, 2024 | seekingalpha.comVaxcyte, Inc. (5VA.F)July 25, 2024 | nz.finance.yahoo.comBuy Rating Affirmed: Clearside Biomedical’s Innovative Drug Delivery and Promising Clinical TrialsJuly 25, 2024 | markets.businessinsider.comServiceNow, Inc. (NYSE:NOW) Q2 2024 Earnings Call TranscriptJuly 25, 2024 | msn.comDren Bio, Inc.: Dren Bio Announces Strategic Collaboration with Novartis to Develop Novel Targeted Myeloid Engagers for CancerJuly 24, 2024 | finanznachrichten.deAzitra, Inc. Announces Pricing of $10.0 Million Public OfferingJuly 23, 2024 | finance.yahoo.comTurn Biotechnologies, Inc.: Turn Biotechnologies Signs Global Licensing Agreement with HanAll Biopharma to Develop Eye and Ear TherapiesMay 28, 2024 | finanznachrichten.deFSD Pharma Inc.: FSD Pharma Provides Corporate UpdateMay 24, 2024 | finanznachrichten.de"EMBRACING INTERNATIONAL ALLIANCES" SWISS BIOTECH INNOVATION ON DISPLAY AT THE BIO 2024 INTERNATIONAL CONVENTION IN SAN DIEGO JUNE 3-6, 2024May 22, 2024 | tmcnet.comBiopharmaceuticals Contract Manufacturing Global Market Report 2024May 21, 2024 | finance.yahoo.comAtossa Therapeutics, Inc.: Atossa Therapeutics Announces Last Patient, Last Dose in its Phase 2 Karisma-Endoxifen Clinical TrialMay 15, 2024 | finanznachrichten.deCybin Inc. (CYBN)May 15, 2024 | ca.finance.yahoo.com Get Innovate Biopharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for INNT and its competitors with MarketBeat's FREE daily newsletter. Email Address We recommended Palantir in 2021, now we’re recommending this... (Ad)My research indicates there is only one investment that can meet AI's unprecedented demand for energy. Click to get the name and ticker symbol INNT Media Mentions By Week INNT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. INNT News Sentiment▼0.000.60▲Average Medical News Sentiment INNT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. INNT Articles This Week▼03▲INNT Articles Average Week Get Innovate Biopharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for INNT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies VAXX News Today AMPE News Today EFTR News Today PHVS News Today LLY News Today NVO News Today JNJ News Today ABBV News Today MRK News Today AZN News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:INNT) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Innovate Biopharmaceuticals Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Innovate Biopharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free INNT Stock Alerts